Chaperoning cell death: a critical dual role for Hsp90 in small-cell lung cancer

被引:45
作者
Workman, Paul [1 ]
Powers, Marissa V. [1 ]
机构
[1] Inst Canc Res, Haddow Labs, Canc Res UK, Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England
关键词
D O I
10.1038/nchembio0807-455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical probes reveal Hsp90 to be a key molecule for the control of apoptosis in small-cell lung cancer - with important implications for Hsp90 biology and cancer treatment.
引用
收藏
页码:455 / 457
页数:4
相关论文
共 14 条
[1]   Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models [J].
Banerji, U ;
Walton, M ;
Raynaud, F ;
Grimshaw, R ;
Kelland, L ;
Valenti, M ;
Judson, I ;
Workman, P .
CLINICAL CANCER RESEARCH, 2005, 11 (19) :7023-7032
[2]   Tumor selectivity of Hsp90 inhibitors: The explanation remains elusive [J].
Chiosis, Gabriela ;
Neckers, Len .
ACS CHEMICAL BIOLOGY, 2006, 1 (05) :279-284
[3]  
Chiosis G, 2006, CURR OPIN INVEST DR, V7, P534
[4]  
Hostein I, 2001, CANCER RES, V61, P4003
[5]   A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors [J].
Kamal, A ;
Thao, L ;
Sensintaffar, J ;
Zhang, L ;
Boehm, MF ;
Fritz, LC ;
Burrows, FJ .
NATURE, 2003, 425 (6956) :407-410
[6]   Inhibitors of the HSP90 molecular chaperone: Attacking the master regulator in cancer [J].
McDonald, Edward ;
Workman, Paul ;
Jones, Keith .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (11) :1091-1107
[7]  
Nylandsted J, 2002, CANCER RES, V62, P7139
[8]  
Pacey S, 2006, HANDB EXP PHARM, V172, P331
[9]   Structure and mechanism of the Hsp90 molecular chaperone machinery [J].
Pearl, Laurence H. ;
Prodromou, Chrisostomos .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :271-294
[10]  
Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO